Bridgewater Associates’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.4M Buy
+19,296
New +$4.89M 0.02% 580

Other funds holding ASND

Bridgewater Associates's ASND Position: Q3 2026 in Review

Bridgewater Associates opened a new position in Ascendis Pharma (ASND) in Q3 2026: 19,296 shares worth $4.4M. The stake represents 0.02% of the portfolio and ranks #580 among its holdings.

347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Bridgewater Associates held 19,296 shares of Ascendis Pharma worth $4.4M as of Q3 2026.
  • Ascendis Pharma was a new Bridgewater Associates position in Q3 2026.
  • Ascendis Pharma made up 0.02% of Bridgewater Associates's portfolio in Q3 2026, its #580 holding.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.